Cardioselective beta-blockers for chronic obstructive pulmonary disease

Author:

Salpeter Shelley R1,Ormiston Thomas M2,Salpeter Edwin E3

Affiliation:

1. Stanford University; Department of Medicine; 215 Brookwood Rd Woodside CA USA 94062

2. Santa Clara Valley Medical Center; Department of Medicine; 751 S. Bascom Avenue San Jose CA USA 95128

3. (Deceased), Cornell University; Ithaca NY USA

Publisher

Wiley

Subject

Pharmacology (medical)

Reference108 articles.

1. Labetalol, beta blockers, and acute deterioration of chronic airway obstruction;Adam;Clinical and experimental hypertension. Part A, Theory and Practice,1982

2. A comparison of oral metoprolol and propranolol in patients with chronic bronchitis;Anderson;The Journal of International Medical Research,1980

3. Effects of a new cardioselective beta-adrenergic blocker (atenolol) on airway resistance in chronic obstructive disease;Beil;Arzneimittel-Forschung,1977

4. Effect of beta-adrenergic blockade on hyperventilation and exercise tolerance in emphysema;Butland;Journal of Applied Physiology,1983

5. Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise;Change;Internal Medicine Journal,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3